Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer

CompletedOBSERVATIONAL
Enrollment

229

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

February 28, 2015

Conditions
Breast Cancer
Trial Locations (19)

1700

Kantonsspital Freiburg, Fribourg

3012

Klinik Engeried / Praxis Oncocare, Bern

3600

SpitalSTS AG Simmental-Thun-Saanenland, Thun

4031

Universitaetsspital-Basel, Basel

4600

Kantonsspital Olten, Olten

6000

Kantonsspital Luzern, Lucerne

6500

Istituto Oncologico della Svizzera Italiana, Bellinzona

7000

Kantonsspital Graubünden, Chur

8008

Brust-Zentrum Seefeld, Zurich

8063

Triemli Stadtspital / Frauenklinik, Zurich

8401

Kantonsspital Winterthur, Winterthur

8501

Kantonsspital Frauenfeld / Brustzentrum Thurgau, Frauenfeld

9006

Tumorzentrum ZeTUP, Sankt Gallen

9007

Kantonsspital St. Gallen, Sankt Gallen

CH-5404

Kantonsspital Baden, Baden

CH-3010

Inselspital, Bern, Bern

CH-2501

Spitalzentrum Biel, Biel

CH-4410

Kantonsspital Liestal, Liestal

CH-8091

UniversitaetsSpital, Zurich

All Listed Sponsors
lead

Swiss Cancer Institute

OTHER

NCT01926964 - Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer | Biotech Hunter | Biotech Hunter